Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
12,602,265
-
Total 13F shares
-
5,372,509
-
Share change
-
+371,325
-
Total reported value
-
$240,988,874
-
Price per share
-
$44.84
-
Number of holders
-
101
-
Value change
-
+$16,505,748
-
Number of buys
-
56
-
Number of sells
-
46
Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q1 2022
As of 31 Mar 2022,
IRADIMED CORP - Common (IRMD) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,372,509 shares.
The largest 10 holders included
Nine Ten Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, Soleus Capital Management, L.P., BlackRock Inc., VANGUARD GROUP INC, Russell Investments Group, Ltd., RK Capital Management, LLC, Ranger Investment Management, L.P., ACADIAN ASSET MANAGEMENT LLC, and RESOURCE CONSULTING GROUP INC.
This page lists
101
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.